Warning: We observe an increase of emails from fake travel portals like . "travelhosting.co.uk". We never send links to such portals so be vigilant!

Jun 8 – 11, 2021 Online only
Europe/Berlin timezone
Note: Each session block has its own zoom session, so please choose the correct link from the timetable!

Development of DD Neutron Generator for life sciences and health

Jun 9, 2021, 1:00 PM
2h
Poster Neutrons and complementary methods in biology Poster Session

Speaker

Rakesh Dubey (NeutronGate Oy)

Description

Neutrons techniques such as Neutron Small Angle Scattering (SANS), Neutron Macro-molecular Crystallography (NMX), Neutron Reflection (NR) are the popular non invasive probes in life sciences and health. All these neutronic instrumentation have been employed in studying the morphology of large molecules and macro-molecular complexes , the drug molecules and their interactions with the biological molecules and other unique structural information's.

These studies are being carried out by neutrons produced  via nuclear  reactions  with  accelerators  (e.g.  LINAC,  cyclotron,  Van  de  Graaff  based  accelerators)  with  large  yields,  up  to  1014  n/s,  with  substantial  cost  and  complexity of operation.  Recently developed neutron generators (NG) have almost same flux, easy to operate, low-budget , long life, fully controlled , portable and  compact.

In present work, we will try to look the feasibility of recently developing compact, controlled, safe, high flux neutron sources for numerous applications in life sciences. We will also discuss its limit and opportunities in all kinds of biological, health, research and development. Such as, these sources are already started acting as an alternative of conventional nuclear reactor/accelerator, by addressing the radio pharmaceutical nuclei production, boron neutron capture therapy, elemental composition of bone (specially Mn), non invasive radiography etc issues.

Primary author

Rakesh Dubey (NeutronGate Oy)

Presentation materials

There are no materials yet.